Eli Lillys obesity drug now available in U.S. pharmacies…
Eli Lilly & Co. LLY said Tuesday its new obesity drug Zepbound has been added to a major pharmacy benefit…
Over the past decade, December been especially kind to Broadcom (AVGO) and Eli Lilly (LLY).…
Pro Research: Wall Street takes on Eli Lillys prospects…
Amphastar is IBD Stock Of The Day as the biotech stock revs up marketing of Baqsimi, a drug purchased this…
Eli Lilly extends tender offer to buy Point Biopharma to Dec. 15…
Both of these stocks have been big winners this year. But one could be better positioned to extend that winning…
Both of these stocks have been big winners this year. But one could be better positioned to extend that winning…
Eli Lilly said on Friday the U.S. Food and Drug Administration (FDA) gave a second approval for its drug Jaypirca,…
Pfizer (PFE) has suffered another setback in its efforts to develop a weight-loss pill — and thats good news for…
The Investing Club holds its Morning Meeting every weekday at 10:20 a.m. ET.…
Eli Lilly has a well-rounded business that can be a good fit for all types of investors.…
Investors’ have lost their appetite for Pfizer (shares down about 40% this year) and turned their heads toward injectable weight…
…
By John Vandermosten, CFA
NASDAQ:LEXX
READ THE FULL LEXX RESEARCH REPORT
Lexaria Bioscience Corporation (NASDAQ:LEXX) reports fiscal full year 2023 results along with…
Here are the biggest calls on Wall Street on Thursday.…
Electronic health records say tirzepatide, the active ingredient in Mounjaro and Zepbound, is better at reducing weight than semaglutide, the…
Electronic health records say tirzepatide, the active ingredient in Mounjaro and Zepbound, is better at reducing weight than semaglutide, the…
The Investing Club releases the Homestretch weekday audio feature in time for the last hour of trading on Wall Street.…
…
The expansion of Gateway Labs to San Diego reaffirms the strength and depth of the partnership between Alexandria (ARE) and…
Eli Lilly (LLY), Novo Nordisk (NVO) and Novartis (NVS) have outperformed the industry this year.…
Eli Lillys Mounjaro is significantly more effective than Novo Nordisks Ozempic in producing weight loss, a real-world study found…
Patients on Eli Lillys Mounjaro were more likely to lose weight and experienced larger reductions in body weight compared to…
Dublin, Nov. 27, 2023 (GLOBE NEWSWIRE) -- The "Global Synthetic Hormones Market: Focus on Product Type, Application, Route…
Eli Lilly, Accenture, TJX, Novo Nordisk and Salesforce are included in this Analyst Blog.…
…
Todays Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), Accenture plc (ACN)…
Eli Lilly (LLY) plans to build a $2.5 billion manufacturing plant in Germany. Novo Nordisk (NVO) plans to invest $2.3…
Its a lot more likely than it sounds.…
Its a lot more likely than it sounds.…
Lilly (LLY) is making rapid pipeline progress in areas like obesity, diabetes and Alzheimers. Mounjaro and Zepbound are expected to…
Could AstraZeneca be an under-rated buy right now?…
Could AstraZeneca be an under-rated buy right now?…
The Tema Cardiovascular and Metabolic ETF holds positions in around 20 companies, including Novo Nordisk and Eli Lilly.…
Investors have favored an exciting billion-dollar opportunity at Eli Lilly.…
Through this expansion, Eli Lilly (LLY) intends to expand its global manufacturing footprint to support the rising demand for its…
Eli Lilly just received FDA approval for its obesity medication Zepbound, the sister treatment to its blockbuster drug Mounjaro.…
(Amt von Hernandez im ersten Absatz korrigiert)
BERLIN (dpa-AFX) - Der US-Pharmakonzern…
(im ersten Satz des dritten Absatzes muss es korrekt Europa heißen. Zudem wurde ein Satz zu Abnehmspritzen…
Eli Lilly and Co (NYSE:LLY) has announced plans for a new $2.5 billion high-tech manufacturing site in Germany to expand…
BERLIN (dpa-AFX) - Der US-Pharmakonzern Eli Lilly will mit mehr als zwei Milliarden Euro eine…
Shares of Eli Lilly & Co. LLY rose 0.67% in premarket trading Friday after drug giant announced plans to spend…
Retail flows into Eli Lilly spiked to a more than two-year high in November, as small investors rushed to buy…
Retail investors crowd into Eli Lilly after weight-loss drug approval…
…
These companies have been attracting plenty of attention lately.…
Is it too late to invest in Eli Lillys stock?…
Is it too late to invest in Eli Lillys stock?…
Eli Lilly plans new 2 billion euro German plant -source…